Newtyn Management’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History

Newtyn Management’s Portfolio PRTK Stock Details PRTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-764,274	Closed	-$1.69M	–	51
2023 Q2	$1.69M	Buy	+764,274	New	+$1.59M	0.4%	32

Newtyn Management's PRTK Position: Q3 2023 in Review

Newtyn Management sold out of Paratek Pharmaceuticals, Inc. (PRTK) in Q3 2023, closing a stake of 764,274 shares — an estimated $1.69M sold.

Newtyn Management first reported a position in PRTK in Q2 2023 and held it in 1 quarter. The position peaked at $1.69M in Q2 2023. 0 funds tracked by Wall St. Rank hold PRTK as of Q3 2023.

Newtyn Management reported no remaining Paratek Pharmaceuticals, Inc. position as of Q3 2023 after selling out during the quarter.
Newtyn Management sold 764,274 Paratek Pharmaceuticals, Inc. shares in Q3 2023, an estimated $1.69M.
Newtyn Management first reported a position in Paratek Pharmaceuticals, Inc. in Q2 2023 and held it in 1 quarter.
Newtyn Management's Paratek Pharmaceuticals, Inc. position peaked at $1.69M in Q2 2023.
0 funds tracked by Wall St. Rank held Paratek Pharmaceuticals, Inc. as of Q3 2023.

Based on Newtyn Management's 13F filing for Q3 2023, filed 14 Nov 2023.